Pharmesis International Ltd. (SGX:BFK)

Pharmesis International Ratios and Metrics

Market cap in millions SGD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 11, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	10	12	18	3	3	3
Market Cap Growth	1.07%	-33.91%	573.89%	7.89%	-27.33%	-47.37%
Enterprise Value	13	14	21	5	4	4
Last Close Price	0.33	0.38	0.57	0.10	0.11	0.15
PE Ratio	-	-	11.78	-	-	13.89
PS Ratio	1.30	1.50	1.44	0.32	0.26	0.31
PB Ratio	1.02	1.18	1.58	0.27	0.23	0.27
P/TBV Ratio	1.05	1.21	1.62	0.29	0.25	0.29
P/FCF Ratio	24.09	27.75	-	-	2.04	-
P/OCF Ratio	21.50	24.76	-	-	1.97	24.90
EV/Sales Ratio	1.56	1.78	1.67	0.56	0.42	0.40
EV/EBITDA Ratio	-	-	34.91	-	-	8.93
EV/EBIT Ratio	-	-	55.85	-	-	19.59
EV/FCF Ratio	28.92	32.93	-	-	3.34	-
Debt / Equity Ratio	0.28	0.28	0.26	0.31	0.29	0.28
Debt / EBITDA Ratio	-	-	4.12	-	-	5.89
Debt / FCF Ratio	6.65	6.65	-	-	2.61	-
Net Debt / Equity Ratio	0.21	0.21	0.19	0.13	-0.06	0.05
Net Debt / EBITDA Ratio	-3.78	-3.78	3.60	-4.36	2.68	1.36
Net Debt / FCF Ratio	4.82	4.82	-3.29	-0.58	-0.50	-3.40
Asset Turnover	0.41	0.41	0.67	0.50	0.53	0.57
Inventory Turnover	1.83	1.83	2.95	1.88	2.65	3.20
Quick Ratio	0.55	0.55	0.79	0.58	0.82	0.92
Current Ratio	0.96	0.96	1.06	1.09	1.12	1.21
Return on Equity (ROE)	-7.34%	-7.34%	13.14%	-8.82%	-5.42%	3.33%
Return on Assets (ROA)	-3.14%	-3.14%	1.25%	-1.90%	-1.66%	0.72%
Return on Invested Capital (ROIC)	-7.93%	-7.57%	2.71%	-4.86%	-4.32%	1.62%
Return on Capital Employed (ROCE)	-9.50%	-9.50%	3.20%	-5.10%	-4.30%	1.70%
Earnings Yield	-7.56%	-6.57%	8.49%	-34.12%	-27.61%	7.20%
FCF Yield	4.15%	3.60%	-3.63%	-83.72%	49.05%	-5.71%
Buyback Yield / Dilution	-6.13%	-6.13%	-13.08%	-14.85%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.